Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3479622 | 1.00 | BACE1 (0.61) | BACE1HSD11B1 | |
| SCHEMBL3479443 | 0.88 | BACE1 (0.58) | BACE1 | |
| SCHEMBL3479511 | 0.88 | BACE1 (0.58) | BACE1 | |
| SCHEMBL3479445 | 0.88 | BACE1 (0.58) | BACE1 | |
| SCHEMBL3479520 | 0.86 | BACE1 (0.73) | BACE1HSD11B1 | |
| SCHEMBL3479519 | 0.86 | BACE1 (0.73) | BACE1HSD11B1 | |
| SCHEMBL13031126 | 0.84 | BACE1 (0.49) | BACE1 | |
| SCHEMBL757005 | 0.84 | BACE1 (0.51) | BACE1HSD11B1 | |
| Hydrochloric Acid SCHEMBL754776 | 0.84 | BACE1 (0.51) | BACE1HSD11B1 | |
| SCHEMBL12293372 | 0.83 | BACE1 (0.57) | BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2063889-A2 | SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | Merck & Co., Inc. (US) | 2009-06-03 | — | — | EP | disclosed |
| WO-2008030412-A2 | SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | MERCK & CO., INC. (US) | 2008-03-13 | — | — | WO | disclosed |